Skip to content

Handwriting Interventions for People With Parkinson's

Handwriting Interventions for People With Parkinson's

Status
Terminated
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03369587
Enrollment
48
Registered
2017-12-12
Start date
2017-11-02
Completion date
2022-04-21
Last updated
2023-07-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Keywords

Handwriting, Micrographia

Brief summary

Background: Problems with handwriting are frustrating and debilitating and affect the majority of people with Parkinson's. Manifest as micrographia it is a distinctive feature of the condition characterised by small handwriting and/or a progressive reduction in size through a sentence\[2\] coupled with a reduction in writing speed and legibility. In Parkinson's impaired automaticity is thought to contribute to handwriting deficits and attention has been shown to improve both 'consistent' (small handwriting) and 'progressive' (progressive reduction in letter size through a sentence) aspects of the symptom. Moreover, recent interventional studies indicate handwriting may be improved through practice. This study is investigating a novel handwriting practice stimulus to improve symptoms of micrograpthia Question: Is a diverging line cued handwriting intervention potentially more effective at improving symptoms of mircograpthia than a parallel line cued handwriting intervention in people with Parkinson's? Specifically, an assessor blind randomised controlled exploratory trial will: 1. Estatimate the effect of the intervention on measures of: Handwriting amplitude (consistent and progressive reduction), hand writing performance and percieved handwriting difficulties. 2. Explore the appropriateness of these outcome measures 3. Explore the approriateness of eligibilty criteria 4. Explore intervention fidelity 5. Explore participants views of the intervention Design: A phase II exploratory randomised controlled trial of a handwriting intervention with an active comparator control group and blinded assessments Setting: The intervention will be carried out at home Sample size: This study is not designed to determine efficacy. The aim to recruit a total of 50 people (25 people per group) in order to estimate the effects on outcome measures and achieve the aims of this exploratory trial. Assessment: Participants will be asked to follow their usual Parkinson's medication regime and if they have ON and OFF periods, assessments will be carried out during ON state. Duration and follow-up: the assessment is schedule 0Weeks (baseline), 6weeks (end intervention) and 12weeks (follow up). Assessments will be carried out by a researcher blind to trial arm allocation using all outcome measures.

Interventions

BEHAVIORALHandwriting Practice

Self-directed home handwriting practice daily for 6 weeks

Sponsors

European Parkinson's Therapy Centre
CollaboratorUNKNOWN
Oxford Brookes University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Assessor Blind to group allocation

Intervention model description

A phase II exploratory randomised controlled trial of a handwriting intervention with an active comparator control group and blinded assessments

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Over 18 years old * Diagnosis of idiopathic Parkinson's disease * A score of ≤3 on the Hoehn and Yahr scale * Self-reported problem with handwriting (≥1 UPDRSII, 2.7) * Able to communicate in Italian * Following a stable medication regimen (no changes in the last 2 weeks and anticipated changes for the course of the study).

Exclusion criteria

* Severe depression or psychosis (history of), * reduced cognition that would preclude active involvement or capacity to consent (according to stages outlined in metal capacity act (ie trigger, information, existing diagnosis, functional test)) * Orthopaedic, neurological or other condition that significantly impairs hand function, * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Micrograpthia: Area of 'el' 8 character text sequence writing task6 weeksArea (maximum height x maximum width) of handwritten cursive 'elelelel' character sequence measured to the nearest of 0.5mm
Self-reported problem with handwriting: Item 2.7 on the Movement Disorders Society Unified Parkinson's Rating Scale6 weeksA scale from 0-4 (0: normal: no problems, 4: severe: most or all words cannot be read) asking 'Over the past week, have people usually had trouble reading your handwriting?'
Writing speed: Time taken to write an Italian proverb6 weeksTime taken to the nearest 10th second to hand write the sentence (written across one line): 'Chi lascia la via vecchia per la nuova, sa quello che lascia ma non sa quello che trova'
Writing amplitude: Area of the both 'lascia' contained in an Italian proverb6 weeksArea (maximum height x maximum width) of 'lascia' contained in handwritten sentence: 'Chi lascia la via vecchia per la nuova, sa quello che lascia ma non sa quello che trova'. Measured to the nearest 0.5mm

Secondary

MeasureTime frameDescription
Legibility of Free writing6 weeksRatio between total number of words written and total number of legible words written during a 5 minutes of free writing task: A reflection on the day
Micrograpthia: Area of 'el' 8 character text sequence writing task12 weeksArea (maximum height x maximum width) of handwritten cursive 'elelelel' character
Writing amplitude: Area of the both 'lascia' contained in an Italian proverb12 weeksArea (maximum height x maximum width) of 'lascia' contained in handwritten sentence: 'Chi lascia la via vecchia per la nuova, sa quello che lascia ma non sa quello che trova'. Measured to the nearest 0.5mm
Writing speed: Time taken to write an Italian proverb12 weeksTime taken to the nearest 10th second to hand write the sentence (written across one line): 'Chi lascia la via vecchia per la nuova, sa quello che lascia ma non sa quello che trova'
Self-reported problem with handwriting: Item 2.7 on the Movement Disorders Society12 weeks0-4 scale (0: normal: no problems, 4: severe: most or all words cannot be read) asking 'Over the past week, have people usually had trouble reading your handwriting?'
EQ-5D-5L6 weeksStandardized Instrument to measure health outcome
Micrograpthia under cognative motor interference: Area of 'el' 8 character text sequence writing task6 weeksArea (maximum height x maximum width) of handwritten cursive 'elelelel' character sequence performed concurrently with cognative task (serial 3 subtraction). Measured to the nearest of 0.5mm

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026